Skip to content

Tenofovir and Truvada licensed in South Africa

Brazil demands 60% efavirenz price cut, or may break patent

Maraviroc recommended for accelerated approval in the US

Abbott offers Aluvia to Thailand in return for compulsory licensing halt

Discovery of an HIV inhibitor in human blood points to new type of fusion inhibitor

Resistance already emerging in first months of treatment despite viral load decline

Outcomes of paediatric antiretroviral treatment in resource-limited settings are promising, MSF shows

Speed of viral load decline is a sign of more effective antiretroviral regimen

HIV treatment now reaching 28% of those in need worldwide, says WHO